Edition:
United Kingdom

Achaogen Inc (AKAO.OQ)

AKAO.OQ on NASDAQ Stock Exchange Global Market

1.63USD
6:08pm GMT
Change (% chg)

$-0.14 (-8.17%)
Prev Close
$1.77
Open
$1.77
Day's High
$1.84
Day's Low
$1.57
Volume
152,085
Avg. Vol
236,843
52-wk High
$15.00
52-wk Low
$1.57

Chart for

About

Achaogen, Inc. is a late-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. The Company is involved in researching and developing plazomicin, its lead product candidate, for the... (more)

Overall

Beta: 1.53
Market Cap(Mil.): $644.48
Shares Outstanding(Mil.): 42.23
Dividend: --
Yield (%): --

Financials

  AKAO.OQ Industry Sector
P/E (TTM): -- 83.95 33.59
EPS (TTM): -3.06 -- --
ROI: -66.68 -0.80 15.05
ROE: -92.67 -0.14 16.62

Achaogen's antibiotic gets FDA nod for urinary tract infections

June 26 The U.S. Food and Drug Administration approved Achaogen Inc's antibiotic to treat adults with complicated urinary tract infections, the company said on Tuesday.

26 Jun 2018

Earnings vs. Estimates